Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (The ABC Study)

Trial Profile

Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (The ABC Study)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2018

At a glance

  • Drugs Abatacept (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Therapeutic Use
  • Acronyms ABC
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism
    • 06 Dec 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top